Dr. John Russell Durkin, MD

Dr. Durkin practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Durkin's NPI, 1336567635, was assigned on April 3, 2014. Dr. Durkin holds New Mexico license MD2018-0092.

Dr. Durkin's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Durkin's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Durkin practices. Vendor and product names are available with a free account.

Dermatology is Dr. Durkin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Durkin is licensed in New Mexico.

CMS data shows 710 Medicare services from Dr. Durkin across 11 procedure codes in 2024, for 327 Medicare patients. Medicare paid $28,984 for them. Every service was in an office.

CMS counts 327 Medicare patients who saw Dr. Durkin in 2024. The largest group is 65 to 74, with 148 patients. 60% of them have high blood pressure, and 60% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Durkin's median patient age at 69, with 52% women.

In 2024, Dr. Durkin wrote 666 Medicare Part D claims for 213 patients. 82% of them were for generic drugs. CMS names the drug for 522 of them, across 21 drugs with 11 or more claims each, at $593,584 in total drug cost. In 2023, CMS named 357 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Durkin for performance year 2024, reported as part of a group. Dr. Durkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 344 procedures of removal of skin lesions by Dr. Durkin, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Durkin, published from 2020 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Microscopy, Confocal, Skin Neoplasms and Skin. Dr. Durkin has published most often in JAAD Case Rep. Dr. Durkin's most frequent co-authors are Catherine Ndjeukam Tchanque-Fossuo, MD, MS, Aimee Caroline Smidt, MD and Emily M. Altman, MD.

Dmand AI links Dr. Durkin to 2 clinical trials. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Durkin that name 1 trial.

CMS Open Payments shows 248 general payments to Dr. Durkin from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $106,696. It also lists 10 research payments totaling $1,417 from 2017 to 2025, naming 1 clinical trial.